Release Date: 30/03/16 08:25 Summary: Full Year Statutory Accounts Price Sensitive: No Download Document 1.28MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%